Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Patrick Schummer"'
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/d85fc502832147ebb2eb847d9ea01b3f
Autor:
Dirk Schadendorf, Lisa Zimmer, Bastian Schilling, Selma Ugurel, Valerie Glutsch, Anja Gesierich, Matthias Goebeler, Jürgen C Becker, Sebastian Haferkamp, Christian Posch, Michael Weichenthal, Ulrike Leiter, Christoffer Gebhardt, Patrick Schummer, Hermann Kneitz, Detlef Klein
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
Merkel cell carcinoma is a rare, highly aggressive skin cancer with neuroendocrine differentiation. Immune checkpoint inhibition has significantly improved treatment outcomes in metastatic disease with response rates to programmed cell death protein
Externí odkaz:
https://doaj.org/article/1cc2750e45564ddcada930fb89b042c9
Autor:
Alexander Thiem, Hermann Kneitz, Patrick Schummer, Stefan Herz, David Schrama, Roland Houben, Matthias Goebeler, Bastian Schilling, Anja Gesierich
Publikováno v:
Acta Dermato-Venereologica, Vol 97, Iss 10, Pp 1252-1254 (2017)
Externí odkaz:
https://doaj.org/article/4a8168cf0f394e1798e32ba4d0b996df
Autor:
Kristin, Faverio, Wiebke K, Peitsch, Tatiana, Görig, Sylke, Schneider-Burrus, Friderike, Benzel, Matthias, Goebeler, Patrick, Schummer, Alaa, Badran, Marthe-Lisa, Schaarschmidt, Wolfgang, Harth, Rotraut, Mössner, Christian, Kromer
Summary Background and Objectives Treatment options for moderate‐to‐severe hidradenitis suppurativa (HS) comprise antibiotics, biologics, and different surgical methods. These approaches differ substantially regarding the treatment process, succe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f59dcdf2fc0377a7d9daf9aa6db74f
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20936
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/20936
Autor:
Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe, Carmen Loquai
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5543
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies of the skin with poor survival outcomes in advanced stages of the disease. Recent clinical trials demonstrated the efficacy of checkpoint-inhibitors (CPI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f6d9ec347fe08104d3d9296c4a64e7
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21056
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/21056
Autor:
Patrick Schummer, Bastian Schilling
Publikováno v:
British Journal of Dermatology. 187:283-284
Linked Article: Bai et al. Br J Dermatol 2022; 187:401–410.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a21fc8f2736c9a033290d14a9cb47aa9
https://doi.org/10.1111/bjd.21621
https://doi.org/10.1111/bjd.21621
Publikováno v:
American Journal of Clinical Dermatology
Approximately 50% of all melanomas harbor an activating BRAF mutation. In patients suffering from an advanced melanoma with such a somatic alteration, combined targeted therapy with a BRAF and MEK inhibitor can be applied to significantly increase th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b1fbb575002e51eb94e1408ae95c822
http://europepmc.org/articles/PMC7371660
http://europepmc.org/articles/PMC7371660
Autor:
Kristin Faverio, Wiebke K. Peitsch, Tatiana Görig, Sylke Schneider‐Burrus, Friderike Benzel, Matthias Goebeler, Patrick Schummer, Alaa Badran, Marthe‐Lisa Schaarschmidt, Wolfgang Harth, Rotraut Mössner, Christian Kromer
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGLiteratur. 20(11)
Die Behandlungsoptionen für mittelschwere bis schwere Hidradenitis suppurativa (HS) umfassen Antibiotika, Biologika und verschiedene chirurgische Verfahren. Diese Ansätze unterscheiden sich stark bezüglich des Behandlungsprozesses, der Erfolgsrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::606a3e0eefccaae4668a37810e5ef11a
https://pubmed.ncbi.nlm.nih.gov/36383976
https://pubmed.ncbi.nlm.nih.gov/36383976
Autor:
Sophia Kreft, Valerie Glutsch, Anne Zaremba, Patrick Schummer, Peter Mohr, Imke Grimmelmann, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Max Sachse, Frank Meiss, Andrea Forschner, Sebastian Haferkamp, Julia Welzel, Patrick Terheyden, Rudolf Herbst, Jochen Utikal, Martin Kaatz, Carsten Weishaupt, Alexander Kreuter, Dirk Debus, Pia Duecker, Anca Sindrilaru, Harald Löffler, Gaston Schley, Michael Weichenthal, Dirk Schadendorf, Selma Ugurel, Anja Gesierich, Bastian Schilling
Publikováno v:
European journal of cancer (Oxford, England : 1990). 167
Objectives: Forty to sixty percent of patients with advanced melanoma show primary resistance to PD-1-based immunotherapy, 30–40% of initial responders also progress. Here, we evaluated the outcome of second-line targeted therapy (TT) after progres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38afbb45b2cdaff961d0a64e20d7c7e
https://pubmed.ncbi.nlm.nih.gov/35366571
https://pubmed.ncbi.nlm.nih.gov/35366571
Autor:
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, Anja Gesierich, Matthias Goebeler, Detlef Klein, Christian Posch, Christoffer Gebhardt, Sebastian Haferkamp, Lisa Zimmer, Jürgen C Becker, Ulrike Leiter, Michael Weichenthal, Dirk Schadendorf, Selma Ugurel, Bastian Schilling
Merkel cell carcinoma is a rare, highly aggressive skin cancer with neuroendocrine differentiation. Immune checkpoint inhibition has significantly improved treatment outcomes in metastatic disease with response rates to programmed cell death protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fdd31f515a586e2d607c86f33f1c72c
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-304613
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-304613